14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RSPI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for RespireRx Pharmaceuticals Inc. stock after losing 0%
(Updated on May 17, 2024)

Sell candidate since May 15, 2024 Loss -5.56% PDF

No changes to the price of RespireRx Pharmaceuticals Inc. stock on the last trading day (Friday, 17th May 2024). During the last trading day the stock fluctuated 5.88% from a day low at $0.0009 to a day high of $0.0009. The price has fallen in 5 of the last 10 days and is down by -5.56% for this period.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.51% during the next 3 months and, with a 90% probability hold a price between $0.0005 and $0.0008 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RSPI Signals & Forecast

There are few to no technical positive signals at the moment. The RespireRx Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.0009 and $0.0009. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 02, 2024, and so far it has fallen -22.73%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for RespireRx Pharmaceuticals Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0008. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.00005 between high and low, or 5.88%. For the last week the stock has had daily average volatility of 12.84%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RSPI) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect RespireRx Pharmaceuticals Inc. to open at $0.0009, and during the day (based on 14 day Average True Range), to move between $0.0007 and $0.0010, which gives a possible trading interval of +/-$0.0001 (+/-14.25%) up or down from last closing price. If RespireRx Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 28.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0008 (5.88%) than the resistance at $0.0009 (5.88%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is RespireRx Pharmaceuticals Inc. stock A Buy?

RespireRx Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.051 Strong Sell Candidate Unchanged

Predicted Opening Price for RespireRx Pharmaceuticals Inc. of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
$0.0009 ( 1.96%) $0.0009

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RSPI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0009 7.84 %
R2 0.0009 5.60 %
R1 0.0009 4.21 %
Current price: 0.0009
Support S1 0.0008 -0.286 %
S2 0.0008 -1.67 %
S3 0.0008 -3.92 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0010 17.65 %
R2 0.0010 11.76 %
R1 0.0009 5.88 %
Current price 0.0009
Support S1 0.0008 -5.88%
S2 0 .
S3 0 .

FAQ

What is the symbol for RespireRx Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for RespireRx Pharmaceuticals Inc. is RSPI and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell RespireRx Pharmaceuticals Inc. Stock?
RespireRx Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy RespireRx Pharmaceuticals Inc. Stock?
RespireRx Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy RespireRx Pharmaceuticals Inc. Stock.

What's the current price of RespireRx Pharmaceuticals Inc. Stock?
As of the end of day on the May 17, 2024, the price of an RespireRx Pharmaceuticals Inc. (RSPI) share was $0.0009.

What is the 52-week high and low for RespireRx Pharmaceuticals Inc. Stock?
The 52-week high for RespireRx Pharmaceuticals Inc. Stock is $0.0191 and the 52-week low is $0.0006.

What is the market capitalization of RespireRx Pharmaceuticals Inc. Stock?
As of the May 17, 2024, the market capitalization of RespireRx Pharmaceuticals Inc. is 310.606K.
Click to get the best stock tips daily for free!

About RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals. RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. It has two drug platforms comprising ResolutionRx, a pharmaceutical cannabinoids platform, which includes dronabinol that acts upon the CB1 and CB2 endocannabinoid receptors for use in chemotherapy-induced nausea and vomiting, as well as for anorexia in patients with AIDS and o... RSPI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT